Transfusion Journal/ transfusion.org
Aug 28, 2025, 18:54
Albert Farrugia: When Will FV Deficiency Get the Attention It Deserves?
Albert Farrugia, Clinical professor at The University of Western Australia, shared an insightful post on LinkedIn:
“The largest series, as far as I’m aware, on the use of FX concentrate in this extremely rare deficiency.
When are we going to see some effort for FV deficiency. I anticipate efficacy with many of the bypassing agents.
It’s disappointing not to see FV deficient patients included in the trials.
Read the full article:”
Article: Characterization and management of patients with hereditary factor X deficiency: A case series
Authors: Meera Chitlur, Lauren E. Amos, Mark T. Reding, Cynthia Sabo, Suchitra S. Acharya
Stay updated with Haemostasis Today.
-
Jan 10, 2026, 15:47Haematologica Journal Presents Review series on von Willebrand Disease
-
Jan 10, 2026, 15:15Stefan Gerner on Stroke Care and Subarachnoid Hemorrhage
-
Jan 10, 2026, 15:02Dr Manikanta Receives AHA Fellowship to Investigate Platelet-Dependent Nucleic Acid-Sensing Pathways
-
Jan 10, 2026, 14:40Last day at ASH25 from Riten Kumar
-
Jan 10, 2026, 08:56Shivanand Kumatagi Reflects on His Visit to Rela Hospital
-
Jan 10, 2026, 08:48Mitchell Elkind: Why Is The American Heart Association Holding a Brain Health Symposium?
-
Jan 10, 2026, 08:41Fiona Robinson Invites You to NBDF Webinar on Research Grants
-
Jan 10, 2026, 08:30Melissa Korn Takes Front Page Award for Her WSJ Piece on Experiencing a Pulmonary Embolism
-
Jan 10, 2026, 08:20Aymar Akilimali on Malaria in the Democratic Republic of Congo